Top 5 Risers
|
| Stock |
Rating |
Analysis |
| CLMT |
STRONGBUY |
The projected value for Calumet is still rising quickly even though past earnings have already improved significantly. |
| CF |
STRONGBUY |
The long term projected growth rate for CF is rising, and this is happenening at a time when historical earnings have already increased significantly. |
| AIG |
STRONGBUY |
An increasingly positive growth rate of past earnings, along with improving expectations for long term growth, make AIG a good prospect for high returns. |
| SCHL |
BUY |
Scholastic has been gaining recognition from analysts as a good canditate for achieving higher than expected earnings along with higher overall projected valuation. |
| SPPI |
BUY |
Spectrum Pharmaceuticals has shown a remarkable increase in projected value recently, with the majority of analysts expecting higher than previously expected earnings. |